Prof Dan Peer, PhD: Founder and Inventor. Prof Peer is a principal investigator and Professor who leads an NIH-funded laboratory at Tel Aviv University, Israel. Prof Peer completed his education in biochemistry and biophysics from Tel Aviv University, Israel (TAU). From 2005 to 2008, he worked at Harvard Medical School. He then joined the Department of Cell Research and Immunology, in the Faculty of life sciences at TAU to establish the laboratory of nanomedicine. Peer’s research was one of the first to demonstrate systemic delivery of RNAi using targeted nano-carriers to the immune system, and the first to utilize RNAi for in vivo validation of new drug targets within the immune system. Prof. Peer’s work was pioneering in the field of gut inflammation and he was involved in the development of antibodies that block lymphocytes homing into the gut during Inflammatory bowel disease. His work is published in premier scientific journals and he is the editor and author of several books in the field of nanomedicine. In addition, he is an associate editor of Journal of Controlled Release, and the editor (biology and medicine) in Nanotechnology. He is also a member of the editorial boards of numerous journals. Prof Peer has received more than 20 awards and honors, is a member of the Israel Young Academy of Science, and holds 45 pending and granted patents. He co-founded three companies based on his work aiming to bring the area of Nanomedicine into clinical practice.